(Reuters) – Britain’s drug regulator on Thursday approved GSK and Vir Biotechnology’s antibody based COVID-19 treatment, Xevudy, for people with mild-to-moderate COVID-19 who are at high risk of developing severe…
Trending News
February 5, 2026
December 20, 2025
December 9, 2025
November 28, 2025
November 28, 2025





